avatrombopag maleate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack
AUST R: 375471
Active ingredients:
avatrombopag maleate

Dosage form:
Tablet, film coated

Sponsor:
Swedish Orphan Biovitrum Pty Ltd

Phone:
1800 570 605

From
24 Aug 2026
to
30 Nov 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals